Articles From: - Alaska USA Federal Credit Union Taps Cardtronics to Expand Surcharge-Free Access in Northwest to - Delta Redefines Cabin, Upgrades Premium Economy Options

EQT Corporation (NYSE: EQT) today announced the Company’s 2015 capital expenditure (CAPEX) forecast of $2.5 billion, excluding business development and land acquisitions.
Sign-up for - EQT Announces 2015 Operational Forecast investment picks
Sign-up for - MGIC Releases Monthly Operating Statistics investment picks TORONTO, ONTARIO --
Sign-up for - Caledonia Mining Corporation: Resignation of Mr Stefan Hayden as a Non Executive Director investment picks
CHONGQING, China , Dec.
Sign-up for - Country Style Cooking Restaurant Chain Announces Strategic Cooperation with Yimutian investment picks
MapQuest , Inc., today launched a weeklong program dedicated to providing Denver Public School students with an “Hour of Code” instruction.
Sign-up for 2014/12/8 - MapQuest Professors Host “Hour of Code” Academy investment picks
bluebird bio, Inc. (Nasdaq: BLUE) today announced data from eight subjects treated with LentiGlobin BB305 drug product.
Sign-up for - bluebird bio Announces Data Demonstrating First Four Patients with β-Thalassemia Major Treated with LentiGlobin™ are Transfusion-Free investment picks
Q4 Revenues Increase 5.0% to $1.3 Billion, Organic Growth of 3.8% NEW YORK, Dec.
Sign-up for - ABM Industries Announces 2014 Fourth Quarter Financial Results investment picks
Shares of Manchester United PLC (MANU) declined in the extended session Monday after the soccer team announced an offering from a large shareholder.
Sign-up for - Manchester United shares decline on large share offering investment picks
Sign-up for - Nasdaq November 2014 Volumes investment picks
Genesis Energy, L.P. (NYSE:GEL) announced today that Grant Sims, CEO, will make a scheduled presentation at the Wells Fargo 2014 Energy Symposium beginning at 2:55 a.m. (EST) on Tuesday, December 9, 2014, in New York City.
Sign-up for - Genesis Energy, L.P. to Present at the Wells Fargo Securities 2014 Energy Symposium investment picks
Allied World Assurance Company Holdings, AG (NYSE:AWH) today announced that it has approved a quarterly dividend equal to $0.225 per share payable on January 2, 2015 to shareholders of record on December 23, 2014.
Sign-up for - Allied World to Pay Quarterly Dividend investment picks
Terreno Realty Corporation (NYSE: TRNO), an acquirer, owner and operator of industrial real estate in six major coastal U.S. markets, announced today the closing of a new $100 million five-year unsecured term loan.
Sign-up for - Terreno Realty Corporation Closes $100 Million Five-Year Unsecured Term Loan investment picks
Goblins vs Gnomes™ , the explosive first expansion to Blizzard Entertainment’s fast-paced online strategy card game Hearthstone ® : Heroes of Warcraft™, is available around the world beginning today! Introducing more than 120 new cards—including an all-new type of minion, Mechs— Goblins vs Gnomes opens up countless new strategic possibilities for Hearthstone players of every skill level.
Sign-up for 2014/12/8 - Goblins vs Gnomes™ Activated! investment picks
The Hospitality Sales & Marketing Association International (HSMAI) will recognize The Pfister Hotel’s 120 th Anniversary Marketing Campaign with a silver Adrian Award for its winning entry in the 58 th annual Adrian Awards, the largest and most prestigious travel marketing competition globally.
Sign-up for - The Pfister® Hotel’s 120th Anniversary Marketing Campaign Wins Prestigious Adrian Award investment picks
Computer Science Education Week (CSED), a national initiative to promote computer science education across the country, launches in Boulder today and continues through Saturday, December 13.
Sign-up for - Computer Science Education Week Launches in Boulder investment picks
Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, announced today the presentation of results from the company’s Phase 1 trial of EPZ-5676, a potent and selective inhibitor of the DOT1L histone methyltransferase (HMT). Epizyme, along with its partner Celgene, is developing EPZ-5676 for the treatment of acute leukemia with alterations in the MLL gene (MLL-r) or partial tandem duplications within MLL (MLL-PTD). The trial found that EPZ-5676 was generally safe and well tolerated across all dose cohorts and showed clinical and biological activity.
Sign-up for - Epizyme DOT1L Inhibitor EPZ-5676 Shows Clinical and Biological Activity in Adult Patients with Acute Leukemias in Phase 1 Trial investment picks
ICF International (NASDAQ:ICFI), a leading provider of consulting services and technology solutions to government and commercial clients, has named Jim Lawler senior vice president for human resources (HR). Mr.
Sign-up for - ICF International Names Jim Lawler Senior Vice President for Human Resources investment picks
TD Ameritrade, Inc. (“TD Ameritrade”), a broker-dealer subsidiary of TD Ameritrade Holding Corporation (NYSE:AMTD), is today releasing the Investor Movement Index ® reading for November 2014.
Sign-up for - TD Ameritrade’s Investor Movement Index: IMX Double Dips in November investment picks
-Potential Biomarkers of Response to CB-839 Identified in Myeloma Cells -Synergy of CB-839 With Pomalidomide Demonstrated in Multiple Myeloma Models SOUTH SAN FRANCISCO, Calif., Dec.
Sign-up for - Calithera Presents Preclinical Study Findings for CB-839 at the 56th American Society of Hematology Annual Meeting investment picks
2014/12/8 CUMBERLAND, MD --
Sign-up for 2014/12/8 - Police Academy's Michael Winslow to Perform Two Shows at Rocky Gap Casino Resort's Bonkerz Comedy Club investment picks
National victim support organization adopts cloud-based solution to provide quick and targeted emergency response BURLINGTON, Massachusetts , December 8, 2014 /PRNewswire/ -- ClickSoftware Technologies Ltd .
Sign-up for 2014/12/8 - Victim Support Selects ClickSoftware's ShiftExpert via the Salesforce AppExchange investment picks
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today presented new preclinical translational data showing the complementary effects of inhibiting both PI3K-delta and PI3K-gamma , two enzymes known to play a role in regulating the growth and survival of certain types of potentially fatal blood cancers, including indolent non-Hodgkin lymphoma (iNHL) and chronic lymphocytic leukemia (CLL). This translational research also highlights the important role that PI3K-gamma plays in forming and maintaining the protective tumor microenvironment.
Sign-up for - Infinity Reports New Translational Research and Updated Phase 1 Data of Investigational Oncology Compound Duvelisib at American Society of Hematology Annual Meeting investment picks
BILLERICA, Mass., Dec.
Sign-up for - CSP Inc. Announces Key Executive Management Team Appointment investment picks ORLANDO, FL --
Sign-up for - Wyndham Vacation Ownership Named Among "Best Places to Work" in Southern Nevada investment picks
Delta One, First Class and Delta Comfort+ offer premium experiences; Main Cabin and Basic Economy offer options for all customers ATLANTA , Dec.
Sign-up for - Delta Redefines Cabin, Upgrades Premium Economy Options investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.


Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: - Alaska USA Federal Credit Union Taps Cardtronics to Expand Surcharge-Free Access in Northwest to - Delta Redefines Cabin, Upgrades Premium Economy Options
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent